More costs than benefits from screening for cardiovascular disease with computed tomography in the DANCAVAS study

Niels Holmark Andersen¹, Torben Jørgensen^{2

3}, John Brandt Brodersen^{4

5

6}

Affiliations

¹ Department of Cardiology, Aalborg University Hospital, Hobrovej 18-22 Aalborg, Denmark.
² Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.
³ Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Nordre Fasanvej 57, Hovedvejen, Entrance 5, 2000 Frederiksberg, Denmark.
⁴ Centre of General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
⁵ The Research Unit for General Practice in Region Zealand, Copenhagen, Denmark.
⁶ The Research Unit for General Practice, Department of Social Medicine, University of Tromsø, Tromsø, Norway.

Editorial

Niels Holmark Andersen et al. Eur Heart J. 2023.

. 2023 Jan 1;44(1):68-69.

doi: 10.1093/eurheartj/ehac634.

Niels Holmark Andersen¹, Torben Jørgensen^{2

3}, John Brandt Brodersen^{4

5

6}

¹ Department of Cardiology, Aalborg University Hospital, Hobrovej 18-22 Aalborg, Denmark.
² Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.
³ Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Nordre Fasanvej 57, Hovedvejen, Entrance 5, 2000 Frederiksberg, Denmark.
⁴ Centre of General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
⁵ The Research Unit for General Practice in Region Zealand, Copenhagen, Denmark.
⁶ The Research Unit for General Practice, Department of Social Medicine, University of Tromsø, Tromsø, Norway.

No abstract available

Conflict of interest statement

Conflict of interest: None declared.

Incidental detection in the DANCAVAS trial was limited by design and did not bias the cost effectiveness conclusion.
Søgaard R, Diederichsen A, Lindholt J. Søgaard R, et al. Eur Heart J. 2023 Jan 1;44(1):70. doi: 10.1093/eurheartj/ehac646. Eur Heart J. 2023. PMID: 36370030 No abstract available.

Cost effectiveness of population screening vs. no screening for cardiovascular disease: the Danish Cardiovascular Screening trial (DANCAVAS).
Søgaard R, Diederichsen ACP, Rasmussen LM, Lambrechtsen J, Steffensen FH, Frost L, Egstrup K, Urbonaviciene G, Busk M, Lindholt JS. Søgaard R, et al. Eur Heart J. 2022 Nov 1;43(41):4392-4402. doi: 10.1093/eurheartj/ehac488. Eur Heart J. 2022. PMID: 36029019 Clinical Trial.